CGRP monoclonal antibodies : summary and effectiveness - Migraine
Frontiers Efficacy and Safety of Monoclonal Antibody Against Calcitonin Gene-Related Peptide or Its Receptor for Migraine: A Systematic Review and Network Meta-analysis
Dual Therapy With Anti‐CGRP Monoclonal Antibodies and Botulinum Toxin for Migraine Prevention: Is There a Rationale? - Pellesi - 2020 - Headache: The Journal of Head and Face Pain - Wiley Online Library
Efficacy and safety of monoclonal antibody against calcitonin gene-related peptide or its receptor for migraine patients with prior preventive treatment failure: a network meta-analysis, The Journal of Headache and Pain
Monoclonal antibodies against calcitonin gene-related peptide in chronic migraine: an adjusted indirect treatment comparison
Mode and site of action of therapies targeting CGRP signaling, The Journal of Headache and Pain
Hometown Highlights: CGRP-Related Treatments for Headache - Practical Neurology
Long-term safety, tolerability, and efficacy of fremanezumab in migraine
Pharmaceuticals, Free Full-Text
CGRP ligand and receptor monoclonal antibodies for migraine prevention: Evidence review and clinical implications
